237 related articles for article (PubMed ID: 25028517)
1. The three Mycobacterium tuberculosis antigen 85 isoforms have unique substrates and activities determined by non-active site regions.
Backus KM; Dolan MA; Barry CS; Joe M; McPhie P; Boshoff HI; Lowary TL; Davis BG; Barry CE
J Biol Chem; 2014 Sep; 289(36):25041-53. PubMed ID: 25028517
[TBL] [Abstract][Full Text] [Related]
2. Mycolyltransferase from
Goins CM; Dajnowicz S; Smith MD; Parks JM; Ronning DR
J Biol Chem; 2018 Mar; 293(10):3651-3662. PubMed ID: 29352107
[No Abstract] [Full Text] [Related]
3. The mycolyltransferase 85A, a putative drug target of Mycobacterium tuberculosis: development of a novel assay and quantification of glycolipid-status of the mycobacterial cell wall.
Elamin AA; Stehr M; Oehlmann W; Singh M
J Microbiol Methods; 2009 Dec; 79(3):358-63. PubMed ID: 19857528
[TBL] [Abstract][Full Text] [Related]
4. The structure of Mycobacterium tuberculosis MPT51 (FbpC1) defines a new family of non-catalytic alpha/beta hydrolases.
Wilson RA; Maughan WN; Kremer L; Besra GS; Fütterer K
J Mol Biol; 2004 Jan; 335(2):519-30. PubMed ID: 14672660
[TBL] [Abstract][Full Text] [Related]
5. An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30 kDa major secretory protein (Antigen 85B), a mycolyl transferase.
Anderson DH; Harth G; Horwitz MA; Eisenberg D
J Mol Biol; 2001 Mar; 307(2):671-81. PubMed ID: 11254389
[TBL] [Abstract][Full Text] [Related]
6. SQ109 targets MmpL3, a membrane transporter of trehalose monomycolate involved in mycolic acid donation to the cell wall core of Mycobacterium tuberculosis.
Tahlan K; Wilson R; Kastrinsky DB; Arora K; Nair V; Fischer E; Barnes SW; Walker JR; Alland D; Barry CE; Boshoff HI
Antimicrob Agents Chemother; 2012 Apr; 56(4):1797-809. PubMed ID: 22252828
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis antigen 85A and 85C structures confirm binding orientation and conserved substrate specificity.
Ronning DR; Vissa V; Besra GS; Belisle JT; Sacchettini JC
J Biol Chem; 2004 Aug; 279(35):36771-7. PubMed ID: 15192106
[TBL] [Abstract][Full Text] [Related]
8. FbpA-Dependent biosynthesis of trehalose dimycolate is required for the intrinsic multidrug resistance, cell wall structure, and colonial morphology of Mycobacterium smegmatis.
Nguyen L; Chinnapapagari S; Thompson CJ
J Bacteriol; 2005 Oct; 187(19):6603-11. PubMed ID: 16166521
[TBL] [Abstract][Full Text] [Related]
9. Cyclipostins and cyclophostin analogs inhibit the antigen 85C from
Viljoen A; Richard M; Nguyen PC; Fourquet P; Camoin L; Paudal RR; Gnawali GR; Spilling CD; Cavalier JF; Canaan S; Blaise M; Kremer L
J Biol Chem; 2018 Feb; 293(8):2755-2769. PubMed ID: 29301937
[TBL] [Abstract][Full Text] [Related]
10. Exploring Covalent Allosteric Inhibition of Antigen 85C from Mycobacterium tuberculosis by Ebselen Derivatives.
Goins CM; Dajnowicz S; Thanna S; Sucheck SJ; Parks JM; Ronning DR
ACS Infect Dis; 2017 May; 3(5):378-387. PubMed ID: 28285521
[TBL] [Abstract][Full Text] [Related]
11. Acetylation of trehalose mycolates is required for efficient MmpL-mediated membrane transport in Corynebacterineae.
Yamaryo-Botte Y; Rainczuk AK; Lea-Smith DJ; Brammananth R; van der Peet PL; Meikle P; Ralton JE; Rupasinghe TW; Williams SJ; Coppel RL; Crellin PK; McConville MJ
ACS Chem Biol; 2015 Mar; 10(3):734-46. PubMed ID: 25427102
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of the secreted form of antigen 85C reveals potential targets for mycobacterial drugs and vaccines.
Ronning DR; Klabunde T; Besra GS; Vissa VD; Belisle JT; Sacchettini JC
Nat Struct Biol; 2000 Feb; 7(2):141-6. PubMed ID: 10655617
[TBL] [Abstract][Full Text] [Related]
13. Computational screening for new inhibitors of M. tuberculosis mycolyltransferases antigen 85 group of proteins as potential drug targets.
Gahoi S; Mandal RS; Ivanisenko N; Shrivastava P; Jain S; Singh AK; Raghunandanan MV; Kanchan S; Taneja B; Mandal C; Ivanisenko VA; Kumar A; Kumar R; ; Ramachandran S
J Biomol Struct Dyn; 2013; 31(1):30-43. PubMed ID: 22804492
[TBL] [Abstract][Full Text] [Related]
14. 1
Korycka-Machała M; Viljoen A; Pawełczyk J; Borówka P; Dziadek B; Gobis K; Brzostek A; Kawka M; Blaise M; Strapagiel D; Kremer L; Dziadek J
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31332069
[TBL] [Abstract][Full Text] [Related]
15. Evidence for a partial redundancy of the fibronectin-binding proteins for the transfer of mycoloyl residues onto the cell wall arabinogalactan termini of Mycobacterium tuberculosis.
Puech V; Guilhot C; Perez E; Tropis M; Armitige LY; Gicquel B; Daffé M
Mol Microbiol; 2002 May; 44(4):1109-22. PubMed ID: 12010501
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the in vivo acceptors of the mycoloyl residues transferred by the corynebacterial PS1 and the related mycobacterial antigens 85.
Puech V; Bayan N; Salim K; Leblon G; Daffé M
Mol Microbiol; 2000 Mar; 35(5):1026-41. PubMed ID: 10712685
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and X-ray analysis of a glycoconjugate bound to Mycobacterium tuberculosis antigen 85C.
Ibrahim DA; Boucau J; Lajiness DH; Veleti SK; Trabbic KR; Adams SS; Ronning DR; Sucheck SJ
Bioconjug Chem; 2012 Dec; 23(12):2403-16. PubMed ID: 23190459
[TBL] [Abstract][Full Text] [Related]
18. Pathway to synthesis and processing of mycolic acids in Mycobacterium tuberculosis.
Takayama K; Wang C; Besra GS
Clin Microbiol Rev; 2005 Jan; 18(1):81-101. PubMed ID: 15653820
[TBL] [Abstract][Full Text] [Related]
19. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis.
Belisle JT; Vissa VD; Sievert T; Takayama K; Brennan PJ; Besra GS
Science; 1997 May; 276(5317):1420-2. PubMed ID: 9162010
[TBL] [Abstract][Full Text] [Related]
20. Functional insights from a comparative study on the dynamics of Antigen85 proteins and MPT51 from Mycobacterium tuberculosis.
Sundar S; Annaraj D; Selvan A; Biswas PG; Vijayakumaran R; Anishetty S
J Mol Model; 2015 Dec; 21(12):310. PubMed ID: 26564147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
